Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2021

Nov 15, 2021

SELL
$7.76 - $29.37 $137,437 - $520,172
-17,711 Closed
0 $0
Q2 2021

Aug 16, 2021

SELL
$24.17 - $34.28 $250,594 - $355,415
-10,368 Reduced 36.92%
17,711 $512,000
Q1 2021

May 17, 2021

SELL
$11.61 - $32.08 $78,030 - $215,609
-6,721 Reduced 19.31%
28,079 $840,000
Q4 2020

Feb 12, 2021

BUY
$5.47 - $12.1 $190,356 - $421,080
34,800 New
34,800 $415,000

Others Institutions Holding EPIX

About ESSA Pharma Inc.


  • Ticker EPIX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 44,073,100
  • Market Cap $221M
  • Description
  • ESSA Pharma Inc., a clinical stage pharmaceutical company, focuses on developing novel and proprietary therapies for the treatment of prostate cancer. It develops EPI-7386, an oral candidate that is in a Phase I clinical study for the treatment of patients with metastatic castration-resistant prostate cancer. The company has collaboration agreem...
More about EPIX
Track This Portfolio

Track Maven Securities LTD Portfolio

Follow Maven Securities LTD and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Maven Securities LTD, based on Form 13F filings with the SEC.

News

Stay updated on Maven Securities LTD with notifications on news.